Dissecting Microenvironmental Interactions in Pediatric High-Grade Gliomas that Promote Tumor Growth |
Dana-Farber Cancer Institute / Mariella G. Filbin, MD/PhD |
Crazy 8 Pilots |
2019 |
Massachusetts |
Investigating phase separated condensates in FPD to MDS/AML progression |
Broad Institute / Zuzana Tothova, MD/PhD |
RUNX1 Early Career Investigator Grants |
2019 |
Massachusetts |
Predicting and Overcoming Resistance to Immunotherapy in Pediatric High-Grade Glioma |
Ann & Robert H. Lurie Children's Hospital of Chicago / Oren Becher, MD & Robert Wechsler-Reya, PhD |
Innovation Grants |
2019 |
Illinois |
The anti-tumor immune microenvironment in the Sonic Hedgehog subclass of medulloblastoma |
Emory University / Anna Kenney, PhD |
Innovation Grants |
2019 |
Georgia |
Targeting mechanisms of Siglec15-mediated immune evasion in hematologic malignancies |
Emory University / Christopher Porter, MD |
Innovation Grants |
2019 |
Georgia |
The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade |
University of Florida / Catherine Flores, PhD |
Innovation Grants |
2019 |
Florida |
Single Cell RNA Sequencing of Pediatric High- and Low-Grade Gliomas |
University of Colorado Denver / Adam Green, MD and Jean Mulcahy Levy, MD |
Single-cell Pediatric Cancer Atlas Grant |
2019 |
Colorado |
Live-Cell Surface Proteomic Characterization of Atypical Teratoid Rhabdoid Tumors Using High Throughout Multi-Color Flow |
University of Colorado Denver / Siddhartha S. Mitra, PhD |
Crazy 8 Pilots |
2019 |
Colorado |
Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells |
Stanford University School of Medicine / Alice Bertaina, MD/PhD |
Reach Grants |
2019 |
California |
Preclinical Development of a First-in-Class PCNA Inhibitor for Treating Neuroblastoma |
City of Hope National Medical Center / Linda Malkas, PhD |
Reach Grants |
2019 |
California |